Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Earns Buy Rating from HC Wainwright
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $9.00 price objective on the stock. Other equities research analysts have also recently issued research reports about the company. D. Boral Capital restated a […]
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $9.00 price objective on the stock. Other equities research analysts have also recently issued research reports about the company. D. Boral Capital restated a […]
